Found: 103
Select item for more details and to access through your institution.
Brown Adipose Tissue Activity Following Exposure to the Cold and [18F]FDG Uptake: from Possible Pitfall in Early PET Scans to Metabolic Biomarker.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264188
- By:
- Publication type:
- Article
Single cell radiotracer allocation via immunomagentic sorting (scRadiotracing) to disentangle PET signals at cellular resolution.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264171
- By:
- Publication type:
- Article
Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Prostate Cancer: We have the answers.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264394
- By:
- Publication type:
- Article
Joint EANM, SNMMI and IAEA Enabling Guide: How to Set Up a Theranostics Centre.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264321
- By:
- Publication type:
- Article
Tumor Sink effect: Myth or Reality?
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264119
- By:
- Publication type:
- Article
Lack of adherence to guideline-based imaging prior to subsequent radiation in patients with non-small cell lung cancer: Impact on patient outcomes.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264131
- By:
- Publication type:
- Article
Invited Perspective, Outcome of patients with PSMA-PET/CT screen failure by VISION criteria and treated with 177Lu- PSMA therapy: a multicenter retrospective analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264128
- By:
- Publication type:
- Article
Choice is good at times: the emergence of [<sup>64</sup>Cu]Cu-DOTATATE based somatostatin receptor imaging in the era of [<sup>68</sup>Ga]Ga-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264183
- By:
- Publication type:
- Article
Reply to Letter to the Editor: "18F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study".
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264035
- By:
- Publication type:
- Article
Repetitive early FAPI-PET acquisition comparing FAPI-02, FAPI-46 and FAPI-74: methodological and diagnostic implications for malignant, inflammatory and degenerative lesions.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264069
- By:
- Publication type:
- Article
Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose <sup>211</sup>At-Labeled Anti-HER2 Single Domain Antibody Fragment.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264071
- By:
- Publication type:
- Article
First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264068
- By:
- Publication type:
- Article
Correlation of <sup>68</sup>Ga-RM2 PET with Post-Surgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263971
- By:
- Publication type:
- Article
The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on <sup>68</sup>Ga-PSMA-11 PET/CT in Primary Prostate Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264101
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluorodihydroxyphenylalanine PET/CT at the Forefront for Initial and/or Pre-surgical Evaluation of Small Intestine Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263984
- By:
- Publication type:
- Article
The Importance of Training, Accreditation and Guidelines for The Practice of Theranostics: The Australian Perspective.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263996
- By:
- Publication type:
- Article
In Vivo Visualization and Quantification of Neutrophil Elastase in Lungs of COVID-19 Patients - A First-In-Human Positron Emission Tomography Study with <sup>11</sup>C-GW457427.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263974
- By:
- Publication type:
- Article
A novel dimeric FAP-targeting small molecule-radio conjugate with high and prolonged tumour uptake.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264036
- By:
- Publication type:
- Article
Radionuclide Evaluation of Brain Death in the Post-McMath Era, epilogue and enigmata.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263972
- By:
- Publication type:
- Article
Posterior Cingulate Involvement Does Not Argue Against LATE.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263968
- By:
- Publication type:
- Article
FAPI-PET Opens a New Window for Understanding of Immune-Mediated Inflammatory Diseases.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263922
- By:
- Publication type:
- Article
Safety and efficacy of holmium-166 radioembolization in hepatocellular carcinoma - the HEPAR Primary study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263823
- By:
- Publication type:
- Article
<sup>68</sup>Ga-Citrate Positron Emission Tomography of Healthy Men: Whole-Body Biodistribution Kinetics and Radiation Dose Estimates.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263884
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA-11 PET/MRI in patients with newly diagnosed intermediate or high-risk prostate adenocarcinoma: PET findings correlate with outcomes after definitive treatment.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263897
- By:
- Publication type:
- Article
Development of Fluorinated NP-59: A Revival of Cholesterol Utilization Imaging with PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263864
- By:
- Publication type:
- Article
Long-term outcomes of submaximal activities of peptide receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumour patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263856
- By:
- Publication type:
- Article
<sup>18</sup>F FDG PET/CT Staging of Head and Neck Cancer: Inter-observer agreement and Accuracy - Results from multicenter ACRIN 6685 Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263902
- By:
- Publication type:
- Article
Letter to the Editor: "18F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study".
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263837
- By:
- Publication type:
- Article
Intraoperative molecular fluorescence imaging of pancreatic cancer by targeting vascular endothelial growth factor: A multicenter feasibility dose-escalation study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263773
- By:
- Publication type:
- Article
Cost-effectiveness of <sup>18</sup>F-FET PET for early treatment response assessment in glioma patients following adjuvant temozolomide chemotherapy.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263790
- By:
- Publication type:
- Article
Tumor sink effect in <sup>68</sup>Ga-PSMA-11 PET: Myth or Reality?
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263802
- By:
- Publication type:
- Article
Total-Body <sup>18</sup>F-FDG PET/CT in Autoimmune Inflammatory Arthritis at Ultra-Low Dose: Initial Observations.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263774
- By:
- Publication type:
- Article
Dual-tracer PET/CT protocol with [18F]-FDG and [68Ga]Ga-FAPI-46 for cancer imaging - a proof of concept.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263835
- By:
- Publication type:
- Article
Temporary reactive response of axillary lymph nodes to COVID-19 vaccination on <sup>18</sup>F-rhPSMA-7.3 PET/CT in patients with prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263758
- By:
- Publication type:
- Article
Virtual Biopsy: Just an AI Software or a Medical Procedure?
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263749
- By:
- Publication type:
- Article
Robot-assisted prostate-specific membrane antigen-radioguided surgery in primary diagnosed prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263743
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of <sup>18</sup>F-labeled Ketoprofen Methyl Esters for Cyclooxygenase-1 Imaging in Neuroinflammation.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263713
- By:
- Publication type:
- Article
Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor Positron Emission Tomography in a Human-sized Swine Model.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263736
- By:
- Publication type:
- Article
Reply to 'Adding non-tumor radiomic features to the prognostic model is bothersome but useful'.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263730
- By:
- Publication type:
- Article
Reply LTE, Single Time Point Tumor Dosimetry Assuming Normal Distribution of tumor kinetics.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263717
- By:
- Publication type:
- Article
A pipeline for automated voxel dosimetry: application in patients with multi-SPECT/CT imaging following 177Lu peptide receptor radionuclide therapy.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263738
- By:
- Publication type:
- Article
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms using <sup>68</sup>Ga-PentixaFor PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263693
- By:
- Publication type:
- Article
Non-Invasive Assessment of Acute Graft vs. Host Disease of the Gastrointestinal Tract Following Allogeneic Haemopoietic Stem Cell Transplantation Using <sup>18</sup>F-FDG PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263688
- By:
- Publication type:
- Article
Explainable Deep Learning Improves Physician Interpretation of Myocardial Perfusion Imaging.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263686
- By:
- Publication type:
- Article
The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer - Going Beneath the Surface with Molecular Imaging.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263684
- By:
- Publication type:
- Article
Distinction of lymphoma from sarcoidosis at FDG PET/CT - evaluation of radiomic-feature guided machine learning versus human reader performance.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263598
- By:
- Publication type:
- Article
Why We Did What We Did: PSMA-PET/CT Selection Criteria for the VISION Trial.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263638
- By:
- Publication type:
- Article
mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263618
- By:
- Publication type:
- Article
Using, <sup>68</sup>Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer: an application of EAU/EANM recommendations in clinical practice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263611
- By:
- Publication type:
- Article
Factors for differential outcome across cancers in clinical molecular-targeted fluorescence imaging.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263674
- By:
- Publication type:
- Article